Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Feb 2022 – 20 Aug 2026, limited by Axis Nifty Next 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty Next 50 Index Fund | Nifty 50 |
|---|---|---|
| 02 Feb 2022 | ₹100.00 | ₹100.00 |
| 20 Jun 2022 | ₹84.22 | ₹86.33 |
| 06 Nov 2022 | ₹102.98 | ₹101.90 |
| 24 Mar 2023 | ₹89.78 | ₹95.30 |
| 09 Aug 2023 | ₹107.55 | ₹110.42 |
| 26 Dec 2023 | ₹125.51 | ₹120.59 |
| 12 May 2024 | ₹153.10 | ₹124.04 |
| 27 Sep 2024 | ₹186.13 | ₹147.24 |
| 13 Feb 2025 | ₹146.27 | ₹129.54 |
| 01 Jul 2025 | ₹165.68 | ₹143.65 |
| 16 Nov 2025 | ₹168.33 | ₹145.73 |
| 04 Apr 2026 | ₹149.97 | ₹127.75 |
| 20 Aug 2026 | ₹180.18 | ₹136.29 |
| Metric | Axis · Direct NAV ₹18.44 Very High risk ★★★★☆ | Category median Index Funds · 375 funds |
|---|---|---|
| +9.65% | +5.66% | |
| +19.84% | +8.82% | |
| — | +9.15% | |
| — | +11.72% | |
| +13.83% | +7.67% | |
| +15.29% | — | |
| +18.68% | +12.67% | |
| — | +13.64% | |
| — | +12.84% | |
| Risk | ||
| 18.27% | 13.97% | |
| 0.73 | 0.24 | |
| 0.98 | 0.36 | |
| -26.35% | -16.12% | |
| Nifty 50 | — | |
| +10.36% | +0.84% | |
| 1.30 | 1.00 | |
| 143.5% | 102.2% | |
| 94.6% | 97.2% | |
| 0.22% | 0.36% | |
| ₹481.51Cr | ₹177.09Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 35% | |
| Karthik Kumar | — | |
| 02 Feb 2022 | — | |
| 50 | — | |
| 32.2% | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.